Search hospitals > Florida > Jacksonville

Mayo Clinic in Florida

Claim this profile
Jacksonville, Florida 32224
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Parotid Gland Cancer
Conducts research for Solid Tumors
Conducts research for Lung Cancer
1617 reported clinical trials
139 medical researchers
Photo of Mayo Clinic in Florida in JacksonvillePhoto of Mayo Clinic in Florida in JacksonvillePhoto of Mayo Clinic in Florida in Jacksonville

Summary

Mayo Clinic in Florida is a medical facility located in Jacksonville, Florida. This center is recognized for care of Cancer, Breast Cancer, Parotid Gland Cancer, Solid Tumors, Lung Cancer and other specialties. Mayo Clinic in Florida is involved with conducting 1,617 clinical trials across 1,507 conditions. There are 139 research doctors associated with this hospital, such as Steven Attia, MD, Sikander Ailawadhi, Mahesh Seetharam, and Amit Mahipal, MD.

Area of expertise

1Cancer
Global Leader
Mayo Clinic in Florida has run 199 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
EGFR positive
2Breast Cancer
Global Leader
Mayo Clinic in Florida has run 187 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
Stage III
ER positive

Top PIs

Clinical Trials running at Mayo Clinic in Florida

Breast Cancer
Lung Cancer
Cancer
Esophageal cancer
Skin Cancer
Multiple Myeloma
Liver Cancer
Breast cancer
Cervical Cancer
Non-Small Cell Lung Cancer
Image of trial facility.

Cancer Vaccine + Pembrolizumab

for Advanced Cancers

This phase I trial tests the safety and tolerability of an experimental personalized vaccine when given by itself and with pembrolizumab in treating patients with solid tumor cancers that have spread to other places in the body (advanced). The experimental vaccine is designed target certain proteins (neoantigens) on individuals' tumor cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving the personalized neoantigen peptide-based vaccine with pembrolizumab may be safe and effective in treating patients with advanced solid tumors.
Recruiting3 awards Phase 1 & 250 criteria
Image of trial facility.

Elacestrant

for Breast Cancer

The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.
Recruiting2 awards Phase 33 criteria
Image of trial facility.

Sacituzumab Govitecan + Pembrolizumab

for Triple Negative Breast Cancer

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Mayo Clinic in Florida?
Where is Mayo Clinic in Florida located?
Who should I call to ask about financial aid or insurance network?
What insurance does Mayo Clinic in Florida accept?
What awards or recognition has Mayo Clinic in Florida received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security